Related Experiment Video
Updated: May 21, 2026

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Crystal structure and biochemical studies of the trans-acting polyketide enoyl reductase LovC from lovastatin
Brian D Ames1, Chi Nguyen, Joel Bruegger
1Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697, USA.
Abstract:
Lovastatin is an important statin prescribed for the treatment and prevention of cardiovascular diseases. Biosynthesis of lovastatin uses an iterative type I polyketide synthase (PKS). LovC is a trans-acting enoyl reductase (ER) that specifically reduces three out of eight possible polyketide intermediates during lovastatin biosynthesis. Such trans-acting ERs have been reported across a variety of other fungal PKS enzymes as a strategy in nature to diversify polyketides. How LovC achieves such specificity is unknown. The 1.9-Å structure of LovC reveals that LovC possesses a medium-chain dehydrogenase/reductase (MDR) fold with a unique monomeric assembly. Two LovC cocrystal structures and enzymological studies help elucidate the molecular basis of LovC specificity, define stereochemistry, and identify active-site residues. Sequence alignment indicates a general applicability to trans-acting ERs of fungal PKSs, as well as their potential application to directing biosynthesis.
More Related Videos
10:41The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
22:00Crystallizing Membrane Proteins for Structure Determination using Lipidic Mesophases
Published on: November 21, 2010
Related Concept Videos
Biosynthesis of Lipids
Biosynthesis in Bacteria
Amino Acid Biosynthetic Pathways
Keto–Enol Tautomerism: Mechanism
Alkylation of β-Ketoester Enolates: Acetoacetic Ester Synthesis
Lipid Catabolism